Acclinate
Acclinate operates the NOWINCLUDED community platform (200K+ members) and the patented e-DICT AI/ML engine to help pharmaceutical companies and CROs improve diversity and predictive enrollment in clinical trials.
- Company typePrivate
- Founded2020
- HeadquartersBirmingham, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Acclinate does
Acclinate is a Birmingham, Alabama-based health technology company that helps pharmaceutical companies and contract research organizations improve diversity in clinical trial enrollment. The company primarily serves enterprise pharma sponsors (named partners include Roche, Merck, BeiGene, Incyte, and Insmed), CROs, and healthcare systems (including UAB Medicine), targeting the persistent underrepresentation of minority populations in clinical research where minority enrollment often runs below 5% despite disproportionate disease burden. Founded in 2020, Acclinate has approximately 51-100 employees and operates from Birmingham with a Delaware corporate domicile.
The company runs a two-product platform architecture. NOWINCLUDED is a B2C community platform with roughly 200,000 members spanning 35+ therapeutic areas that generates authenticated engagement signals through culturally relevant health education, in-person events (over 1,000 conducted), and digital touchpoints. e-DICT (Enhanced Diversity in Clinical Trials) is a patented AI/ML engine that processes those signals into predictive enrollment intelligence, including the proprietary Participation Probability Index, study and site-level insights, demographic forecasting, and real-time dashboards. The Affective Trust Framework — a three-stage Access, Engage, Mobilize model — underpins both products by addressing psychological and trust barriers specific to underrepresented communities. The architecture combines structured predictive analytics with NLP-driven thematic and sentiment extraction from community narratives.
Acclinate generates revenue primarily through enterprise B2B SaaS contracts with pharmaceutical sponsors and CROs, supplemented by professional services revenue from community engagement, event execution, and educational content development. Pricing is quote-based with annual billing cycles and a 'Request a Demo' sales motion, indicating tailored enterprise contracts. The company has expanded distribution through strategic channel partnerships, notably the Good Neighbor Pharmacy (Cencora) pilot, and most recently through a licensed e-DICT deployment to HCN Global that combines a combined 540,000+ multicultural community members. Through May 2024, Acclinate has raised approximately $12 million across multiple funding rounds, with the $7 million Series A led by Cencora Ventures and supported by Labcorp and Latimer Ventures.
Acclinate firmographics
Firmographics- Name
- Acclinate
- Legal name
- Acclinate, Inc.
- Website
- https://acclinate.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Acclinate operates the NOWINCLUDED community platform (200K+ members) and the patented e-DICT AI/ML engine to help pharmaceutical companies and CROs improve diversity and predictive enrollment in clinical trials.
- Ownership category
- akta.pro rank
Acclinate industry classification
Industry- Product category
- Clinical Trial Diversity Technology
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Electronic Data Capture (EDC) Platforms (HLACAOAA)
Keywords
Where Acclinate is headquartered
LocationHeadquarters
- HQ city
- Birmingham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Acclinate business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Pharma and CRO Platform/SaaS Services: B2B SaaS model providing pharmaceutical companies and CROs access to the NOWINCLUDED community platform and e-DICT analytics for clinical trial diversity recruitment and enrollment intelligence. Revenue likely derives from platform subscriptions, licensing fees, and per-study engagement fees.
- Community Engagement Services: Professional services for community engagement, event execution, and educational content development supporting pharma diversity action plans and clinical trial recruitment campaigns.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise pharmaceutical and CRO pricing |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
Acclinate product offering
Product offeringCore offering
Acclinate operates a two-product platform that combines the NOWINCLUDED B2C community platform (200K+ members) with the e-DICT patented AI/ML analytics engine. The company transforms community trust signals into predictive enrollment intelligence, including the proprietary Participation Probability Index (PPI), to help pharmaceutical sponsors and CROs improve diversity and representation in clinical trials across 35+ therapeutic areas.
Product overview
Acclinate operates a two-product platform architecture: NOWINCLUDED is the community-facing B2C engagement platform (200K+ members) that generates authenticated trust and behavioral signals across 35+ therapeutic areas; e-DICT is the proprietary AI/ML engine that processes those signals into predictive enrollment intelligence (Participation Probability Index, demographic forecasting, real-time dashboards). The two products are tightly integrated — NOWINCLUDED feeds community data into e-DICT, which then delivers predictive scoring and insights used by pharmaceutical sponsors and CROs for clinical trial recruitment and retention. Solutions are offered to Pharmaceutical Companies, Contract Research Organizations (CROs), and Community Partners.
Differentiator
Problem solved
Functional benefit
Brands
- NOWINCLUDED: Acclinate's B2C community platform focused on health equity and clinical trial diversity, empowering underrepresented communities to take action for better health.
- e-DICT
Products and services
- NOWINCLUDED NOWINCLUDED is a B2C community platform with 200K+ members that generates structured, authenticated engagement signals across channels and therapeutic areas. It connects underrepresented populations with culturally relevant health education, resources, and clinical trial opportunities through an always-on trust-based engagement model powered by the Affective Trust Framework.
- e-DICT (Enhanced Diversity in Clinical Trials) e-DICT is Acclinate's patented AI/ML engine that transforms community trust signals from NOWINCLUDED into predictive enrollment intelligence, including the Participation Probability Index (PPI), study and site-level insights, demographic forecasting, real-time dashboards, and predictive scoring for pharmaceutical sponsors and CROs.
Quantifiable outcome
- 200K+ community members generating structured, authenticated signals
- +6 more outcomes
Companies that use Acclinate
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles3 records
Acclinate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Acclinate partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship, minor and core.
- HCN GlobalflagshipStrategic partnership announced June 2026 combining multicultural health engagement networks. HCN Global's La Red Hispana, LatinEQUIS, and Melanin Thriving platforms (290K+ individuals) integrated with Acclinate's NOWINCLUDED (220K+ members) through HCN Global becoming a licensed user of Acclinate's e-DICT platform. Enables pharmaceutical sponsors to track engagement across 540K+ combined community members in 35+ therapeutic areas.
- Black Baseball MediaminorStrategic partnership focused on health, education, and empowerment of student-athletes. Awarded two $1,000 scholarships at Wrigley Field in May 2026. Collaboration aims to empower 1 million people to take proactive steps toward better health by integrating health education with athletic development.
- Housing Authority of the Birmingham DistrictcorePartnership to improve health equity through community engagement initiatives in Birmingham district housing communities, expanding access to health education and clinical trial awareness.
- Good Neighbor PharmacycorePartnership with Good Neighbor Pharmacy (GNP) — a network of independent pharmacies owned by Cencora — to explore pharmacies as activation points for community-driven clinical research. Pilot conducted in greater Philadelphia area engaged 228 individuals, demonstrating pharmacies' potential as trusted healthcare touchpoints for research outreach.
- Egality SciencesminorUnited for health equity in Hispanic and African American communities through joint community engagement and clinical research education initiatives.
- Multiple Myeloma Research Foundation (MMRF)coreCollaboration from April to October 2024 addressing disparity in multiple myeloma clinical trial representation. Black/African Americans comprise only 4% of enrollees despite highest incidence rates. Partnership used NOWINCLUDED platform and community engagement to increase awareness, education, and participation in research.
- Alabama Regional Medical ServicescoreNew partnership created to improve health equity and clinical trial access in Alabama communities through community-driven engagement and health education initiatives.
- ProsperminorPartnership on a new platform aimed at reducing health disparities through integrated community engagement and health equity initiatives.
Scale indicators9 records
Recent moves6 records
Expansion highlights7 records
Acclinate competitors and assessment
Company assessmentDirect peers
- Trialbee: Direct competitor in clinical trial patient recruitment and engagement technology. Both companies serve pharma sponsors seeking to improve enrollment diversity and patient matching, and have a documented partnership relationship in the Acclinate data.
- Mendel: AI platform for clinical trial recruitment and patient cohort identification using structured and unstructured medical data. Comparable as an AI-native trial diversity and enrollment intelligence vendor for pharma sponsors.
- SubjectWell: Patient recruitment platform for clinical trials using a curated network of patient communities. Directly comparable GTM in pharma-sponsored enrollment with a network-driven model.
- Deep 6 AI: AI-driven clinical trial patient matching and recruitment platform serving pharma sponsors and research hospitals. Uses structured and unstructured EHR data to accelerate enrollment, comparable in technology approach to e-DICT.
- Antidote (now part of the Clinical Trial Innovation Network): Patient engagement and clinical trial matching platform focused on connecting patients with trials through digital outreach. Directly comparable in mission of broadening trial access and recruitment.
Broad incumbents
- Medable: Decentralized clinical trial technology platform serving pharma and CROs with eCOA, eConsent, and remote engagement. Adjacent competitor addressing patient experience and access in clinical research.
- IQVIA: Global CRO and clinical technology incumbent with extensive patient recruitment, real-world data, and trial optimization capabilities. Overlaps with Acclinate in pharma trial diversity services but operates as a much broader portfolio vendor.
- Castor: Clinical trial EDC and eClinical platform serving pharma, CROs, and academic researchers. Adjacent competitor in the broader clinical trial technology stack serving similar buyer personas.
Emerging players
- Sword Health / Hurdle (health equity focus): Digital health companies building patient engagement and outcomes infrastructure with culturally relevant care models. Adjacent in using community trust and engagement data to address health disparities, though not directly in trial recruitment.
- CMX Research (Egality Sciences): Community-driven clinical research engagement focused on Hispanic/Latino and African American populations. Directly comparable mission and a documented partnership/alliance partner of Acclinate in health equity.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Acclinate social profiles
Digital presenceAcclinate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Acclinate leadership team
Management profileNumber of profiles
Profiles8 records
Acclinate funding detail
Funding detailFunding overview
Funding rounds6 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Acclinate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Acclinate
What does Acclinate do?
Acclinate operates a two-product platform that combines the NOWINCLUDED B2C community platform (200K+ members) with the e-DICT patented AI/ML analytics engine. The company transforms community trust signals into predictive enrollment intelligence, including the proprietary Participation Probability Index (PPI), to help pharmaceutical sponsors and CROs improve diversity and representation in clinical trials across 35+ therapeutic areas.
Is Acclinate a public or private company?
Acclinate is a private company. It is classified as venture growth investor backed and is currently operating.
When was Acclinate founded?
Acclinate was founded in 2020. It employs 51 to 100 people.
Where is Acclinate based?
Acclinate is headquartered in Birmingham, United States, in the North America region.
How does Acclinate make money?
Two revenue lines are on record. Pharma and CRO Platform/SaaS Services are the primary driver. The others are community Engagement Services.
Who are Acclinate's main competitors?
Direct peers on record are Trialbee, Mendel, SubjectWell, Deep 6 AI and Antidote (now part of the Clinical Trial Innovation Network). Broad incumbents are Medable, IQVIA and Castor. Emerging players are Sword Health / Hurdle (health equity focus) and CMX Research (Egality Sciences).
Does Acclinate have an API?
No public API is recorded for Acclinate.
What industry is Acclinate in?
Acclinate's product category is Clinical Trial Diversity Technology. Its primary akta.pro industry code is HLACAOAA, Electronic Data Capture (EDC) Platforms. Its SIC code is 7372.